Form 4: Veracyte Director Evan Jones Reports Acquisition and Disposal of Common Stock
SEC Form 4 Filing
Director Evan Jones reports acquisition of restricted stock units and disposal of common stock.
Summary
- On June 13, 2024, Director Evan Jones acquired 11,473 shares of Common Stock at $0.
- On the same day, Jones disposed of 49,074 shares of Common Stock.
- Following these transactions, Jones directly owns 11,473 shares and indirectly owns 35,173 shares through jVen Capital, LLC.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions by a company director, indicating a neutral sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, which is a common occurrence in the biotechnology industry.
Stakeholder Impact
- The transactions may be of interest to shareholders as they provide insight into the director's view of the company's stock value.
Key Dates
| Date | Description |
|---|---|
| 06/13/2024 | Date of transaction: acquisition of restricted stock units and disposal of common stock |
| 06/17/2024 | Date of signature on the report |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.